Insight Molecular Diagnostics Inc. 8-K

What Happened
Insight Molecular Diagnostics, Inc. (IMDX) filed an 8‑K on April 30, 2026 stating that its Annual Report on Form 10‑K for the year ended December 31, 2025 inadvertently included an incorrect copy of the Third Amended and Restated Bylaws. The previously filed exhibit included certain shareholder voting provisions that are not part of the company’s actual bylaws. The company has filed the correct bylaws as Exhibit 3.1 to this 8‑K and said this correction does not change any other disclosures in the Form 10‑K.

Key Details

• 8‑K filed: April 30, 2026.
• Affected filing: Annual Report on Form 10‑K for the year ended December 31, 2025.
• Issue: Clerical error resulted in inclusion of shareholder voting provisions that are not part of the bylaws.
• Remedy: Corrected Third Amended and Restated Bylaws filed as Exhibit 3.1; company states no other 10‑K disclosures are changed.

Why It Matters
Correct bylaws are part of a company’s governance record and clarify shareholder rights and voting procedures. IMDX’s disclosure indicates this was a clerical correction rather than a substantive change to governance or to financial statements. For investors, this should be viewed as an administrative fix to ensure the public record is accurate; the company affirms there is no impact on financial results or other Form 10‑K disclosures.